---
title: "Nasal spray brands: Which are searched most?"
description: "Compare the nasal spray brands people buy. Share of Search among Vicks, Betadine, Sudafed, Otrivin, Flo, Arm and Hammer, Fess and Rhinocort, the nasal spray brands Brandwave compares worldwide, using the same methodology, market, and reporting period. Branded searches tell you how often people look for a brand by name or related terms. Comparing these searches across competitors helps you see how popular each brand is over time."
canonical: "https://gobrandwave.com/demand/global-en/categories/nasal-spray-brands"
publisher: "Brandwave"
---

# Nasal spray brands: Which are searched most?

Compare the nasal spray brands people buy. Share of Search among Vicks, Betadine, Sudafed, Otrivin, Flo, Arm and Hammer, Fess and Rhinocort, the nasal spray brands Brandwave compares worldwide, using the same methodology, market, and reporting period. Branded searches tell you how often people look for a brand by name or related terms. Comparing these searches across competitors helps you see how popular each brand is over time.

## Key facts

- **Competitive set**: Nasal spray brands
- **Market**: Global
- **Brands compared**: 8
- **Month measured**: Sep 2026
- **Highest Share of Search**: Vicks, 45%

## Which brand is most popular in search among nasal spray brands worldwide?

- In September 2026, Vicks was the most searched among nasal spray brands worldwide, with an estimated 1.2M branded searches and 45% estimated Share of Search within this set.
- Betadine is in 2nd place, 19.6 percentage points behind at 25.4% Share of Search.
- Across the 12 months ending September 2026, Vicks’ estimated Share of Search among nasal spray brands worldwide decreased from 49.4% to 45%.
- Across the 12 months ending September 2026, Betadine’s estimated Share of Search among nasal spray brands worldwide increased from 22.8% to 25.4%.
- Across the 12 months ending September 2026, Sudafed’s estimated Share of Search among nasal spray brands worldwide increased from 15.3% to 17%.
- Across the 12 months ending September 2026, Vicks’ estimated Share of Search among nasal spray brands worldwide peaked at 49.4% in October 2025 and was lowest at 38.2% in April 2026.
- Across the 12 months ending September 2026, Betadine’s estimated Share of Search among nasal spray brands worldwide peaked at 30.7% in June 2026 and was lowest at 20.5% in February 2026.
- Across the 12 months ending September 2026, Sudafed’s estimated Share of Search among nasal spray brands worldwide peaked at 20.5% in February 2026 and was lowest at 13.7% in July 2026.
- Across the 12 months ending September 2026, Otrivin’s estimated Share of Search among nasal spray brands worldwide peaked at 6.5% in December 2025 and was lowest at 4.1% in July 2026.
- Across the 12 months ending September 2026, Flo’s estimated Share of Search among nasal spray brands worldwide peaked at 5.9% in July 2026 and was lowest at 2.4% in December 2025.
- Across the 12 months ending September 2026, Otrivin, Flo, Arm and Hammer, Fess and Rhinocort held steady: their estimated Share of Search among nasal spray brands worldwide each moved less than 0.5 percentage points.

## Compare search popularity between leading brands

- [Vicks vs Betadine: compare search popularity](/demand/global-en/compare/betadine-vs-vicks): 45% against 25.4% Share of Search.
- [Vicks vs Sudafed: compare search popularity](/demand/global-en/compare/sudafed-vs-vicks): 45% against 17% Share of Search.
- [Vicks vs Otrivin: compare search popularity](/demand/global-en/compare/otrivin-vs-vicks): 45% against 5.1% Share of Search.
- [Vicks vs Flo: compare search popularity](/demand/global-en/compare/flo-vs-vicks): 45% against 3.2% Share of Search.
- [Betadine vs Sudafed: compare search popularity](/demand/global-en/compare/betadine-vs-sudafed): 25.4% against 17% Share of Search.
- [Betadine vs Otrivin: compare search popularity](/demand/global-en/compare/betadine-vs-otrivin): 25.4% against 5.1% Share of Search.
- [Betadine vs Flo: compare search popularity](/demand/global-en/compare/betadine-vs-flo): 25.4% against 3.2% Share of Search.
- [Sudafed vs Otrivin: compare search popularity](/demand/global-en/compare/otrivin-vs-sudafed): 17% against 5.1% Share of Search.
- [Sudafed vs Flo: compare search popularity](/demand/global-en/compare/flo-vs-sudafed): 17% against 3.2% Share of Search.
- [Otrivin vs Flo: compare search popularity](/demand/global-en/compare/flo-vs-otrivin): 5.1% against 3.2% Share of Search.

## How did search popularity change for nasal spray brands worldwide in September 2026?

- In September 2026, Vicks gained estimated Share of Search among nasal spray brands worldwide, from 41.9% to 45%.
- In September 2026, Sudafed gained estimated Share of Search among nasal spray brands worldwide, from 15.9% to 17%.
- In September 2026, Betadine lost estimated Share of Search among nasal spray brands worldwide, from 29.2% to 25.4%.
- In September 2026, Flo lost estimated Share of Search among nasal spray brands worldwide, from 3.9% to 3.2%.
- Estimated monthly branded searches for Otrivin worldwide fell 18.2% over 12 measured months, from 165K to 135K in September 2026.
- Estimated monthly branded searches for Rhinocort worldwide fell 18.1% over 12 measured months, from 33.1K to 27.1K in September 2026.

## Share of Search ranking

| Rank | Brand | Share of Search | Estimated monthly branded searches | Change vs prior month | Owned by |
| --- | --- | --- | --- | --- | --- |
| 1 | Vicks | 45% | 1.2M | +23.3% | Vicks |
| 2 | Betadine | 25.4% | 673K | 0.0% | Betadine |
| 3 | Sudafed | 17% | 450K | +22.3% | Sudafed |
| 4 | Otrivin | 5.1% | 135K | +22.7% | Otrivin |
| 5 | Flo | 3.2% | 84.2K | -6.1% | Flo Health |
| 6 | Arm and Hammer | 1.7% | 45.9K | 0.0% | Arm and Hammer |
| 7 | Fess | 1.5% | 40.5K | +22.4% | Fess |
| 8 | Rhinocort | 1% | 27.1K | +22.1% | Rhinocort |

## Historical estimated branded-search demand

| Month | Brand | Estimated monthly branded searches | Share of Search | Rank |
| --- | --- | --- | --- | --- |
| Oct 2025 | Vicks | 1.5M | 49.4% | 1 |
| Oct 2025 | Betadine | 673K | 22.8% | 2 |
| Oct 2025 | Sudafed | 450K | 15.3% | 3 |
| Oct 2025 | Otrivin | 165K | 5.6% | 4 |
| Oct 2025 | Flo | 84.7K | 2.9% | 5 |
| Oct 2025 | Arm and Hammer | 45.9K | 1.6% | 6 |
| Oct 2025 | Fess | 40.5K | 1.4% | 7 |
| Oct 2025 | Rhinocort | 33.1K | 1.1% | 8 |
| Nov 2025 | Vicks | 1.3M | 46.3% | 1 |
| Nov 2025 | Betadine | 673K | 24.6% | 2 |
| Nov 2025 | Sudafed | 450K | 16.4% | 3 |
| Nov 2025 | Otrivin | 165K | 6% | 4 |
| Nov 2025 | Flo | 78.1K | 2.9% | 5 |
| Nov 2025 | Arm and Hammer | 37.5K | 1.4% | 6 |
| Nov 2025 | Fess | 33.1K | 1.2% | 7 |
| Nov 2025 | Rhinocort | 33.1K | 1.2% | 8 |
| Dec 2025 | Vicks | 1.5M | 48.4% | 1 |
| Dec 2025 | Betadine | 673K | 21.6% | 2 |
| Dec 2025 | Sudafed | 550K | 17.7% | 3 |
| Dec 2025 | Otrivin | 201K | 6.5% | 4 |
| Dec 2025 | Flo | 75.8K | 2.4% | 5 |
| Dec 2025 | Arm and Hammer | 37.5K | 1.2% | 6 |
| Dec 2025 | Fess | 33.1K | 1.1% | 7 |
| Dec 2025 | Rhinocort | 33.1K | 1.1% | 8 |
| Jan 2026 | Vicks | 1.5M | 47.9% | 1 |
| Jan 2026 | Betadine | 673K | 21.4% | 2 |
| Jan 2026 | Sudafed | 550K | 17.5% | 3 |
| Jan 2026 | Otrivin | 201K | 6.4% | 4 |
| Jan 2026 | Flo | 105K | 3.3% | 5 |
| Jan 2026 | Fess | 40.5K | 1.3% | 6 |
| Jan 2026 | Arm and Hammer | 38.5K | 1.2% | 7 |
| Jan 2026 | Rhinocort | 33.1K | 1.1% | 8 |
| Feb 2026 | Vicks | 1.2M | 45.3% | 1 |
| Feb 2026 | Betadine | 550K | 20.5% | 2 |
| Feb 2026 | Sudafed | 550K | 20.5% | 3 |
| Feb 2026 | Otrivin | 165K | 6.1% | 4 |
| Feb 2026 | Flo | 100K | 3.7% | 5 |
| Feb 2026 | Arm and Hammer | 37.5K | 1.4% | 6 |
| Feb 2026 | Fess | 33.1K | 1.2% | 7 |
| Feb 2026 | Rhinocort | 33.1K | 1.2% | 8 |
| Mar 2026 | Vicks | 1.1M | 41% | 1 |
| Mar 2026 | Betadine | 673K | 24.7% | 2 |
| Mar 2026 | Sudafed | 550K | 20.2% | 3 |
| Mar 2026 | Otrivin | 165K | 6.1% | 4 |
| Mar 2026 | Flo | 100K | 3.7% | 5 |
| Mar 2026 | Arm and Hammer | 45.9K | 1.7% | 6 |
| Mar 2026 | Fess | 40.5K | 1.5% | 7 |
| Mar 2026 | Rhinocort | 33.1K | 1.2% | 8 |
| Apr 2026 | Vicks | 904K | 38.2% | 1 |
| Apr 2026 | Betadine | 673K | 28.5% | 2 |
| Apr 2026 | Sudafed | 450K | 19% | 3 |
| Apr 2026 | Otrivin | 135K | 5.7% | 4 |
| Apr 2026 | Flo | 83.7K | 3.5% | 5 |
| Apr 2026 | Arm and Hammer | 45.9K | 1.9% | 6 |
| Apr 2026 | Fess | 40.5K | 1.7% | 7 |
| Apr 2026 | Rhinocort | 33.1K | 1.4% | 8 |
| May 2026 | Vicks | 884K | 39% | 1 |
| May 2026 | Betadine | 673K | 29.7% | 2 |
| May 2026 | Sudafed | 368K | 16.2% | 3 |
| May 2026 | Flo | 111K | 4.9% | 4 |
| May 2026 | Otrivin | 110K | 4.9% | 5 |
| May 2026 | Arm and Hammer | 45.9K | 2% | 6 |
| May 2026 | Fess | 40.5K | 1.8% | 7 |
| May 2026 | Rhinocort | 33.1K | 1.5% | 8 |
| Jun 2026 | Vicks | 897K | 40.9% | 1 |
| Jun 2026 | Betadine | 673K | 30.7% | 2 |
| Jun 2026 | Sudafed | 301K | 13.7% | 3 |
| Jun 2026 | Flo | 123K | 5.6% | 4 |
| Jun 2026 | Otrivin | 90.5K | 4.1% | 5 |
| Jun 2026 | Arm and Hammer | 47.1K | 2.1% | 6 |
| Jun 2026 | Fess | 33.1K | 1.5% | 7 |
| Jun 2026 | Rhinocort | 27.1K | 1.2% | 8 |
| Jul 2026 | Vicks | 896K | 40.8% | 1 |
| Jul 2026 | Betadine | 673K | 30.6% | 2 |
| Jul 2026 | Sudafed | 301K | 13.7% | 3 |
| Jul 2026 | Flo | 129K | 5.9% | 4 |
| Jul 2026 | Otrivin | 90.5K | 4.1% | 5 |
| Jul 2026 | Arm and Hammer | 45.9K | 2.1% | 6 |
| Jul 2026 | Fess | 40.5K | 1.8% | 7 |
| Jul 2026 | Rhinocort | 22.2K | 1% | 8 |
| Aug 2026 | Vicks | 967K | 41.9% | 1 |
| Aug 2026 | Betadine | 673K | 29.2% | 2 |
| Aug 2026 | Sudafed | 368K | 15.9% | 3 |
| Aug 2026 | Otrivin | 110K | 4.8% | 4 |
| Aug 2026 | Flo | 89.7K | 3.9% | 5 |
| Aug 2026 | Arm and Hammer | 45.9K | 2% | 6 |
| Aug 2026 | Fess | 33.1K | 1.4% | 7 |
| Aug 2026 | Rhinocort | 22.2K | 0.96% | 8 |
| Sep 2026 | Vicks | 1.2M | 45% | 1 |
| Sep 2026 | Betadine | 673K | 25.4% | 2 |
| Sep 2026 | Sudafed | 450K | 17% | 3 |
| Sep 2026 | Otrivin | 135K | 5.1% | 4 |
| Sep 2026 | Flo | 84.2K | 3.2% | 5 |
| Sep 2026 | Arm and Hammer | 45.9K | 1.7% | 6 |
| Sep 2026 | Fess | 40.5K | 1.5% | 7 |
| Sep 2026 | Rhinocort | 27.1K | 1% | 8 |

## What is being compared

- **Arm and Hammer**: Measured on the search terms “arm and hammer” and “arm hammer”, summed into one figure.
- **Betadine**: Measured on the search term “betadine”.
- **Fess**: Measured on the search term “fess”.
- **Flo**: Measured on the search terms “flo app”, “flo health”, “flo ovulation” and “flo period tracker”, summed into one figure.
- **Otrivin**: Measured on the search term “otrivin”.
- **Rhinocort**: Measured on the search term “rhinocort”.
- **Sudafed**: Measured on the search term “sudafed”.
- **Vicks**: Measured on the search terms “vicks”, “vicks cough”, “vicks humidifier”, “vicks inhaler” and “vicks vaporub”, summed into one figure.

- [Arm and Hammer](/demand/global-en/brands/arm-and-hammer)
- [Betadine](/demand/global-en/brands/betadine)
- [Fess](/demand/global-en/brands/fess)
- [Flo](/demand/global-en/brands/flo)
- [Otrivin](/demand/global-en/brands/otrivin)
- [Rhinocort](/demand/global-en/brands/rhinocort)
- [Sudafed](/demand/global-en/brands/sudafed)
- [Vicks](/demand/global-en/brands/vicks)

## Methodology

- [How is branded search demand measured?](/demand/methodology): Where the figures come from, what they compare, and how they may be reused.

## Frequently asked questions

### Which brand is most popular in search among nasal spray brands worldwide?

In September 2026, Vicks was the most searched among nasal spray brands worldwide, with an estimated 1.2M branded searches and 45% estimated Share of Search within this set. These are worldwide searches for English-language branded terms.

## Cite this page

Brandwave. "Nasal spray brands: Which are searched most?". https://gobrandwave.com/demand/global-en/categories/nasal-spray-brands

This page is also available as HTML at https://gobrandwave.com/demand/global-en/categories/nasal-spray-brands. Brandwave publishes an index of its Markdown pages at https://gobrandwave.com/llms.txt.